Results 101 to 110 of about 1,165 (128)

Use of anti-amyloid therapies for Alzheimer's disease in Brazil: a position paper from the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. [PDF]

open access: yesDement Neuropsychol
Barbosa BJAP   +20 more
europepmc   +1 more source

Guidelines for the use and interpretation of Alzheimer's disease biomarkers in clinical practice in Brazil: recommendations from the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. [PDF]

open access: yesDement Neuropsychol
Studart-Neto A   +20 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Lecanemab in Early Alzheimer’s Disease

New England Journal of Medicine, 2023
Michio Kanekiyo   +2 more
exaly  

Donanemab in Early Alzheimer’s Disease

New England Journal of Medicine, 2021
Liana Apostolova   +2 more
exaly  

Home - About - Disclaimer - Privacy